Search Ontology:
ChEBI
crizotinib
- Term ID
- CHEBI:64310
- Synonyms
-
- (R)-crizotinib
- 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine
- crizotinib
- crizotinibum
- PF 2341066
- PF-2341066
- Definition
- A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
- References
-
- CAS:877399-52-5
- Drug_Central:4187
- KEGG:D09731
- LINCS:LSM-1027
- PMID:21308771
- PMID:22129595
- PMID:22129984
- PMID:22191798
- PMID:22215748
- PMID:22233293
- PMID:22235099
- PMID:22277784
- PMID:22282074
- PMID:22311682
- PMID:22316363
- PMID:22321987
- PMID:22323827
- PMID:22385925
- PMID:22397764
- PMID:22435662
- PMID:22443113
- PMID:24427836
- PMID:24444403
- PMID:24455567
- PMID:24486291
- PMID:24491302
- PMID:24556908
- Reaxys:12133926
- Wikipedia:Crizotinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_part
-
- inverse is_enantiomer_of
-
- is_enantiomer_of
-
Phenotype
Phenotype resulting from crizotinib
Phenotype where environments contain crizotinib
Phenotype modified by environments containing crizotinib
Human Disease Model